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Abstract
Background: Oral contraceptives (OCs) with estrogens and progestins may affect oxidative 
stress (OS) status. 
Study Design: A group of 32 women using oral contraceptives (OCU) containing 0.03 mg 
ethinylestradiol and 3 mg drospirenone has been compared to a matched control group of 30 
non-contraception users (NCU). Blood levels of antioxidants, trace elements and markers of 
lipid peroxidation were assessed by biochemical methods. A microarray analysis of whole 
blood mRNA levels of 200 genes involved in OS-dependant pathway was also performed. 
Results: Levels of zinc, vitamin-E and antibodies to oxidized LDLs were not significantly 
different between the two groups. On the other hand, significant increases in the mean levels 
of lipid peroxides (+176%, p<0.001), oxidized LDLs (+145%, p<0.002), copper (+103%, 
p<0.001), Cu/Zn ratio (+100%, p<0.001) and a significant decrease in the mean level of -
carotene (-41%, p<0.01) were observed in the OCU compared to NCU. There was a highly 
significant positive correlation between the lipid peroxide levels and the copper to zinc ratio. 
From the 200 genes tested by microarray, one coding for HSP70 was significantly up-
regulated (log2 fold change = + 0.45, p<0.02) and one coding for iNOS significantly down-
regulated (log2 fold change = - 0.24, p <0.05) in the OCU compared to the NCU.
Conclusions: The recently-introduced combination of ethinyl oestradiol and drospirenone
induced the heightening of lipid peroxidation correlated with high levels of copper, a situation 
that could be associated with increased cardiovascular risk. 
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1. Introduction
Reactive oxygen species (ROS) are metabolic products of the respiratory chain. It is estimated 
that approximately 1 to 3% of the inhaled oxygen produces ROS. Furthermore, the exposure 
to UV radiations, to air pollutants such as cigarette smoke or ozone, entails an increase of the 
production of ROS. ROS can have beneficial effects by participating, for example, in the 
mechanisms of immunological defenses against infections or detrimental effects linked to the 
oxidation of lipids, proteins and DNA. The body protects itself from noxious effects of ROS 
by a complex antioxidant system consisting of enzymatic antioxidants such as the catalase, 
the glutathione peroxidase (GPx) and superoxide dismutase (SOD) and non-enzymatic
antioxidants such as, for example, vitamins A, C and E, glutathione (GSH) and uric acid. An 
imbalance between the production of ROS and the antioxidant defenses leads to a state of 
oxidative stress (OS) which is involved in the process of ageing and in various 
physiopathological processes such as cancer, diabetes and atherosclerosis [1-3]. The pro- or 
antioxidant effects of estrogens and progestins remain controversial. Various clinical studies 
evaluated the influence of estradiol therapy (ET) and of hormone replacement therapy (HRT) 
associating oral estrogens and progestins on the OS of postmenopausal women.  Some of 
these studies showed protective effects on the OS [ 4-10 ] whereas others showed no 
significant effect on OS [ 11-15]. Surprisingly, only few studies have investigated the effects 
of oral contraceptives (OCs) on the OS. Some studies showed a significant increase of lipid 
peroxides in women using subdermal implants of levonogestrel or injectable depo-medroxy 
progesterone acetate (DPMA) [16-18]. An increase of blood lipid peroxides was observed in 
rats treated with estro-progestative OCs [19] and a decrease of the liposoluble antioxidants 
coenzyme Q10 and -tocopherol was shown in women taking the OC compared to a control 
group not using OCs [20].  More recently, a study assessing the effect of OC on OS in a 
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heightening of lipid peroxides associated with a higher concentration of copper and altered 
liposoluble antioxidant defenses [21]. In the present study, we analyzed the effects on 
biochemical and molecular OS markers of the latest generation OCs in a representative group 
of women18-35 years old.
2. Materials and methods
2.1. Subjects
Sixty-two healthy female subjects participated in the study. The study was approved by and 
performed under the guidelines of the Ethic Committee of the University Hospital of Liège, 
Belgium and informed consent was obtained from each of the subjects before blood sampling. 
The test group consisted in 32 women aged 23.0 ± 3.9 years (mean ± SD) who were regular 
OC users (OCU) and who were recruited during routine gynecology visits. The average 
duration of OC use was of 33 ± 26 months (mean ± SD), ranging from 3 months to 9 years. 
All the OCU were taking a contraceptive pill containing 0.03 mg ethinylestradiol and 3 mg 
drospirenone (DRSP).  The control group consisted of 30 non-contraceptive users aged 29.4 
± 4.3 years (mean ± SD) (NCU) with no other hormonal treatments who were recruited 
during routine gynecology or medically assisted reproduction visits.
All the subjects were of normal body weight and were nonsmokers with no evidence of 
chronic disease. None of the subjects consumed >25 mL alcohol/d or were taking other 
medications, antioxidants, or vitamin supplements. The mean (± SD) body mass indexes 
(BMI) were, respectively, 23.7 ± 2.8 kg/m2 for the NCU group and 21.3± 2.9 kg/m2 for the 
OCU group.
Blood samples for the assessment of OS markers were taken between the third and fifth day 
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Blood samples were drawn on EDTA or Na-heparin as anticoagulant or clot activating gel 
according to the investigated parameter. Blood samples were centrifuged within 4 h after 
sampling and plasma or sera were immediately frozen and kept at -20°C until tested. For 
microarray analysis, whole blood samples were collected on PackGeneTM tubes and 
immediately frozen and kept at -80°C until mRNA extraction.
2.3. Antioxidants and trace element determination
Plasma vitamin-E (-tocopherol) (Vit-E) and -carotene were determined simultaneously by 
HPLC procedure (Alliance Waters, USA) coupled with a diode array detector (PDA 2996, 
Waters, USA) according to the method of Zhao et al. [22]. EDTA plasma samples were 
immediately frozen at -20 °C until analyzed. The plasma concentrations of copper (Cu) and 
zinc (Zn) were determined by inductively coupled plasma-mass spectrometry [23]. 
2.4. Markers of lipid peroxidation 
The analysis of lipid peroxides was performed with the OxyStat commercial kit (OxySat, 
Biomedica Gruppe, Austria). Briefly, the peroxide (-OOH) concentrations are determined by 
a spectrophotometric based method by reaction of the biological peroxides (LOOH) with 
peroxiydase and subsequent color reaction using 3,3’,5,5’-tetramethylbenzidine (TMB) as 
substrate. Oxidized low-density lipoproteins (ox-LDLs) in plasma samples were determined 
spectrophotometrically with a competitive enzyme-linked-immunoassay (ELISA) kit from 
(Immunodiagnostik, Germany). The titers in free antibodies (IgG) against oxidized LDLs 
were assessed with a commercial enzyme immunoassay (Biomedica Gruppe, Austria) using 
Cu2+ oxidized LDLs as antigen. 
2.5. Microarray analysis
We designed and prepared a low-density (200 genes) oligonucleotide microarray for mRNA 
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stress-sensitive pathways. Corresponding oligonucleotides were generated by ArrayDesigner 
3 software (Premier Biosoft Intl, USA) using the Tm parameter = 75°C + 2°C. Probes were 
limited to a length of 60 nucleotides. All oligonucleotide sequences were designed using the 
thermodynamic model optimized for microarrays. To avoid cross-homology, the set of 
oligonuleotides was tested by performing a BLAST analysis against the NCBI "Human Ref 
Seq RNA" database. Oligonucleotide probes were deposited by a robot on chemically pre-
treated glass slides. mRNA were purified from whole blood with the QIAamp RNA Blood 
Mini Kit from Qiagen (QIAGEN gmbH, Germany). A reverse transcription in the presence of 
probes containing the Genisphere 3DNATM capture sequence (Genisphere Inc, USA) was then 
realized. The resulting cDNAs were then hybridized on the microarray. The presence of the 
sample cDNAs were then detected by complementary 3DNATM Capture Reagents 
(Genisphere Inc, USA) that were Cy3-labeled. The acquisition and the analysis of the images 
were realized by means of a scanner GenePix and of the software GenePix Pro 5.0. (Axon 
Instruments, Molecular Devices, U.S.A). All values derived from the image analysis were 
background corrected and normalized by the variance stabilization method of Huber et al.
[24], against a common reference slide. After normalization, outlier arrays were detected and 
removed when their Pearson correlation coefficient was in average lower than 70%. A pool of 
mRNA was used as standard control.
2.6. Statistical analysis
For the biochemical parameters, the differences between groups were analyzed by the non-
parametric Mann-Whitney test. The differences between the median values of both groups 
were considered as significant at p <0.05. The correlations between the various studied 
biochemical parameters were analyzed by using the Pearson coefficient of correlation. The 
correlations between the various parameters were considered as significant at p <0.05. For the 
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limma2 [25] on the two groups. This package makes use of an adapted version of the 
hierarchical model proposed by Lonnstedt and Speed [26]. The central idea is to fit a general 
linear model with arbitrary coefficients and contrasts of interest, to the expression data for 
each gene. The empirical Bayes approach shrinks the estimated sample variances towards a 
pooled estimate, resulting in a far more stable inference [27]. The differences in gene 




Levels of Zn (0.73 ± 0.15 versus 0.75 ± 0.10 mg/L) , Vit-E (11.26 ± 1.76 versus 11.46 ±
2.47 mg/L) and antibodies to oxidized LDL (Ab-ox-LDL) (555.0 ± 501.4 versus 530.5 ±
447.5 U/L) were not significantly different between the two groups. Significant increases in 
the mean levels of LOOH (478.2 ± 194.7 versus 1321.9 ± 356.9 mol/L, p <0.001), ox-LDL 
(503.9 ± 536.3 versus 1236.3 ± 1023.8 ng/mL, p <0.002), Cu (0.86 ± 0.23 versus 1.75 ±
0.36 mg/L, p <0.001), Cu/Zn ratio (1.18 ± 0.21 versus 2.37 ± 0.39, p <0.001) and a 
significant decrease in the mean level of -carotene (0.35 ± 0.22 versus 0.20 ± 0.07 mg/L, p 
<0.01) were observed in the OCU compared to NCU (Table 1).
3.2. Microarray analysis
From the 200 genes tested by microarray analysis, only 2 were significantly differentially 
expressed in the OCU compared to NCU (Fig.1). The first was the gene coding for heat shock 
protein 60 kD (HSP60, + 0.45 log2 fold change between OCU and NCU, adjusted p <0.05) 
and the second was the gene coding for the nitric oxide synthase 2A (NOS2A, - 0.24 log2 fold 
change between OCU and NCU, adjusted p <0.05). 
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Bivariate analysis of  the different parameters showed positive significant correlations 
between the levels of lipid peroxides and the levels of ox-LDL (r = 0.474, p <0.001), Cu (r = 
0.834, p <0.001) and  Cu/Zn ratio (r = 0.834, p <0.001); positive significant correlations 
between the levels of ox-LDL and the levels of Cu (r = 0.423, p <0.001) and Cu/Zn ratio (r =  
0.408, p <0.001); positive correlations between the levels of Cu and the levels of Zn (r = 
0.352, p <0.01) and Cu/Zn ratio (r = 0.905, p <0.001); and negative significant correlations 
between -carotene and the levels of LOOH (r = -0.304, p <0.05), Cu (r = -0.261, p = 0.05) 
and Cu/Zn ration (r = -0.335, p <0.05) (Table 2).
4. DISCUSSION
The effects of estrogens and progestin on oxidative stress are controversial. Estrogens display 
an antioxidant activity by inhibiting the expression and function of the NADP+/NADPH 
oxidase [28, 29], by increasing  the expression and level of activation of the endothelial 
isoform of the nitric oxide synthase (eNOS)  [30] and by stimulating the expression and
activity of the manganese SOD ( MnSOD) and of the extracellular SOD (ecSOD ) [31]. These 
antioxidant activities of estrogens are counteracted by progestins via the activation of the 
NADPH oxidase and the inhibition of the expression and activity of the MnSOD and of the 
ecSOD [32, 33]. A direct pro-oxidant effect of estrogens was shown in experimental models 
in the rat [34] and the Syrian hamster [35]. These pro-oxidant effects of estrogens can 
partially be explained by their metabolism. Indeed, estrogens can be metabolically activated 
into catechol estrogens by the enzymes of cytochrome P450. These last ones are easily auto-
oxidized to ortho-quinone by-products which are powerful oxido-reducing agents capable of 
generating ROS [36]. 
The increase of serum Cu related to OC use is known and has been attributed to the induction 
by estrogens of the hepatic synthesis of the acute phase protein ceruloplasmin, the main Cu 
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factors for a variety of enzymes including CuZn-SOD, an enzyme which participates actively 
in the elimination of ROS [40]. An imbalance between these two trace elements could result 
in a dysfunction of CuZn-SOD and, consequently, a decrease of the protection of lipids 
against oxidation by ROS. There is numerous evidence which suggests that Cu plays a direct 
role in lipid peroxidation [41, 42]. Cu is a pro-oxidant redox-active transition metal while Zn, 
which is redox-inactive, is capable of counteracting the pro-oxidant activity of Cu [43]. An 
association between high serum Cu/Zn ratios and aging on one hand and aging-related 
chronic degenerative diseases on the other hand has been shown [44]. In the same study, the 
Cu levels were positively correlated (and Zn negatively correlated) to the lipid peroxides 
levels. The different OS-sensitive pathways that are influenced by estrogens and/or progestins 
are shown in Fig.2. 
Surprisingly, only two genes were differentially expressed in leucocytes of OCU compared to 
NCU, the heat shock protein 60kD (HSP60) and the inducible nitric oxide synthase (iNOS). 
The increased expression of HSP60 in OCU can be explained by a direct effect of estrogens. 
Indeed, it has been shown that 17-estradiol (E2) and two metabolites (16-hydroxysterone 
and 2-methoxyestradiol) were able to increase the levels of HSP60 transcripts in MCF-7 
breast cancer cells [45]. E2 and the E2 receptor- agonist diarylpropiolnitrile (DNP) have 
been shown to restore the levels of HSP60 in the heart of Sprague-Dawley rats undergoing 
trauma-hemorrhage, a condition where the heat shock protein was impaired [46]. Cu could 
also be involved in the over-expression of HSP60. Indeed, HSP60 mRNA expression was 
specifically reduced in the atria of Cu-deficient rats [47] and the induction of HSP60 in 
response to Cu in a fish hepatoma cell line (PLHC-1) has been shown [48]. Our results 
showed for the first time an in vivo elevation of HSP60 in OCU. The respective role of each 


































































De Groote et al 10 Oral contraception and oxidative stress
Different observations suggest that estrogens and progestins regulate the expression of iNOS 
in different ways, but their conclusions are controversial [49, 50, 51, 52].
Most of the genes involved in the OS-sensitive pathway that are influenced by estrogens 
and/or progestins (Fig. 2) were detected on the microarray but were not significantly changed 
in OCU compared to NCU. This suggests that these pathways are not the main sources of OS 
in OCU. On the contrary, the good correlation of the Cu/Zn ratio with the levels of lipid 
peroxides and with oxidized LDLs suggest that the estrogen-mediated increase of Cu in the 
liver could be a key factor of OS production in OCU. One possible mechanism could be that 
the combination of a mild activation of some OS-sensitive pathways with a important Cu
release initiates a chain reaction involving the production of superoxide (˙O2-), Cu reduction, 
formation of hydroxyl radicals and lipid peroxidation [53, 54]. 
The significant decrease in -carotene levels in the OCU compared to NCU is in agreement 
with the study of Palan et al. [20] and Pincemail et al. [21] and can be attributed to the 
estrogen induction and activation of the retinol binding protein leading to increased
conversion of -carotene into retinol [55].
Several experimental models and numerous clinical observations suggest a major role of OS 
in the process of atherogenesis and cardiovascular diseases [56-59].
It is well known that the cardio vascular side effects of OCs occur mainly in women who 
present other risk factors such as dyslipidemia, smoking, above 35 years of age, excess body 
weight and high blood pressure [60]. The mechanisms by which the physiological and 
environmental factors as well as the lifestyle and food habits act on the state of OS are 
complex and influenced by genetic factors such as the polymorphism of genes coding for 
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angiotensin) or antioxidant activities (Cu/ZnSOD, MnSOD, ecSOD, PON-1, GPX, etc.) [61-
64].
In the present study, we provide evidence for a relationship between OC use and the state of 
OS. The disturbance of the OS markers was documented by a very significant increase of 
lipid peroxides and ox-LDLs, probably in conjunction with an increase in circulating Cu 
induced by estrogens. The OCU group was about 5 years younger in the mean than the NCU 
group. Nothing is known about an age-related effect on the studied parameters in this range of 
age. Increased plasma levels of lipid peroxides and Cu have manly been shown in elderly [65-
67]. If there is a positive correlation between age and the variables measured, the effect we 
have seen might be underestimated. Nevertheless, due to the extent of the differences we 
observed, that should have no impact on the conclusions. These observations are based on a 
cross-sectional comparison. They will need to be confirmed in longitudinal studies in which 
women act as their own control or better still, with randomization to non-steroidal 
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De Groote et al 13 Oral contraception and oxidative stress
Fig. 1.
Volcano graph of gene expression in OCU. Log2 fold changes of OCU versus NCU (x axis) 
are plotted against 1/p (y axis) where p is the Wilcoxon BH adjusted p value between OCU 
and NCU. Differences are considered statistically significant for p < 0.05 (1/p >20).  
Fig. 2.
Schematic representation of estrogens and progestins metabolic pathways involved in 
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Table 1





p value between groups
Lipid peroxides (mol/L) 478.2 (194.7) 1321.9 (356.9) < 0.001
Oxidized LDL (ng/mL) 503.9 (536.3) 1236.3 (1023.8) 0.0015
Ab-ox-LDL (U/mL) 555.0 (501.4) 530.5( 447.5) ns
-tocopherol (mg/L) 11.26 (1.76) 11.46 (2.47) ns
-carotene (mg/L) 0.35 (0.22) 0.20 (0.07) 0.0086
Copper (mg/L) 0.86 (0.23) 1.75 (0.36) < 0.001
Zinc (mg/L) 0.73 (0.15) 0.75  (0.10) ns
Cu/Zn ratio 1.18 (0.21) 2.37 (0.39) < 0.001
Values are means (S.D.). Differences between groups are statistically significant for p <0.05.
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** Correlation is significant at the 0.01 level (2-tailed).
* Correlation is significant at the 0.05 level (2-tailed).
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